Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Bahaa Atamna, Alon Rozental, Mohamed Haj Yahia, Ronit Gurion, Moshe Yeshurun, Pia Raanani, Ofir Wolach

Blood (2024) 144 (Supplement 1): 4476.

https://doi.org/10.1182/blood-2024-208234

Published: 2024

Journal Articles

Belumosudil Is Efficacious for the Management of Heavily Pretreated and Prolonged Chronic Graft-Versus-Host Disease: A Retrospective Multi-Center Real-World Study By the Israel Association for Bone Marrow Transplantation and Cellular Therapy

Ben Varon, Ron Ram, Avichai Shimoni, Batia Avni, Sigal Grisariu, Vered Stavi, Yael Bar-On, Moshe Yeshurun, Ronit Elhasid, Aharon Gefen, Asaf Yanir, Odelia Amit, Dana Yehudai-Ofir, Israel Henig, Tsila Zuckerman

Blood (2024) 144 (Supplement 1): 7338.

https://doi.org/10.1182/blood-2024-206874

Published: 2024

Journal Articles

Impact of Premedication Prior to Platelet Transfusion on Platelet Increment Among Hemato-Oncological Patients

Tamar Berger, Vered Yahalom, Odil Giladi, Eithan Kugler, Tzippy Shochat, Victoria Meirman, Ella Gal, Tetyana Klebovsky, Ofir Wolach, Moshe Yeshurun, Pia Raanani, Liat Shargian, Oren Pasvolsky

Blood (2023) 142 (Supplement 1): 5563.

https://doi.org/10.1182/blood-2023-181310

Published: 2023

Journal Articles

Utility of Echocardiogram in Neutropenic Patients with Gram Positive Bacteremia: A Retrospective Study

Neta Sternbach, Pia Raanani, Dafna Yahav, Liat Shragian, Moshe Yeshurun, Ofir Wolach, Haim Ben zvi

Blood (2023) 142 (Supplement 1): 5830.

https://doi.org/10.1182/blood-2023-178346

Published: 2023

Journal Articles

Efficacy of Luspatercept in Low-Risk Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Irina Amitai, Ronit Gurion, Pia Raanani, Moshe Yeshurun, Ofir Wolach, Drorit Merkel, Yoav Amitai, Anat Gafter-Gvili, Liat Shargian

Blood (2023) 142 (Supplement 1): 6487.

https://doi.org/10.1182/blood-2023-189891

Published: 2023

Journal Articles

Safety and Efficacy of FLAG-Ida Combined with Venetoclax Treatment for Newly Diagnosed and Relapsed / Refractory AML Patients- a Systematic Review

Adi Sherban, Danielle Fredman, Shai Shimony, Moshe Yeshurun, Pia Raanani, Maximilian F. Stahl, Anat Gafter-Gvili, Ofir Wolach

Blood (2022) 140 (Supplement 1): 11716–11717.

https://doi.org/10.1182/blood-2022-163152

Published: 2022

Journal Articles

Sequential Therapy Vs. Salvage Chemotherapy for Patients with AML Refractory to First Induction Regimen- a Bi-Institutional Retrospective Cohort Analysis

Ron Ram, Odelia Amit, Shai Winer, Yakir Moshe, Pia Raanani, Eitan Kugler, Moshe Yeshurun, Irit Avivi, Ofir Wolach

Blood (2022) 140 (Supplement 1): 10637–10638.

https://doi.org/10.1182/blood-2022-164543

Published: 2022

Journal Articles

Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience

Sigal Grisariu Greenzaid, Ron Ram, Mona Kazuli, Dana Yehudai-Ofir, Liat Shargian, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Yael Bar-On, Eran Zimran, Adir Shaulov, Polina Stepensky, Jacob Strahilevitz, Batia Avni

Blood (2022) 140 (Supplement 1): 12833–12834.

https://doi.org/10.1182/blood-2022-164694

Published: 2022

Journal Articles

Humoral Serologic Response to the BNT162b2 Vaccine Afterallogeneic Haematopoietic Cell Transplantation

Moshe Yeshurun, Oren Pasvolsky, Liat Shargian, Dafna Yahav, Maly Rubinstein, Michal Navon Sela, Ofir Wolach, Haim Ben-Zvi, Pia Raanani, Uri Rozovski

Blood (2021) 138 (Supplement 1): 4876.

https://doi.org/10.1182/blood-2021-149979

Published: 2021

Journal Articles

Extracorporeal Photopheresis Induces Netosis in Neutrophils Derived from Patients with Graft-Versus-Host Disease

Idan Goldberg, Galit Granot, Alona Telerman, Shirly Partouche, Moshe Yeshurun, Pia Raanani, Ofir Wolach, Vered Yahalom

Blood (2021) 138 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2021-153655

Published: 2021

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission after 5-Azacitidine and Venetoclax: A Multicenter Retrospective Study

Oren Pasvolsky, Shai Shimony, Ron Ram, Avichai Shimoni, Liat Shargian-Alon, Batia Avni, Ofir Wolach, Tzippy Shochat, Ronit Yerushalmi, Odelia Amit, Pia Raanani, Moshe Yeshurun

Blood (2021) 138 (Supplement 1): 3962.

https://doi.org/10.1182/blood-2021-144772

Published: 2021

Journal Articles

A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study

Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Dana Yehudai-Ofir, Irit Avivi, Orit Gutfeld, Polina Stepensky, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Batia Avni, Ronit Gurion, Yael Bar-On, Ofrat Beyar-Katz, Ronit Gold, Shimrit Ringelstein, Itai Levi, Tzvi Porges, Chava Perry

Blood (2021) 138 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2021-151085

Published: 2021

Journal Articles

Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation - the Diagnostic Yield of Stool Cultures

Tamar Berger, MD, Odil Giladi, MD, Dafna Yahav, MD, Haim Ben-Zvi, Oren Pasvolsky, MD, Liat Shargian-Alon, MD, Ofir Wolach, MD, Uri Rozovski, MD, Pia Raanani, MD, Moshe Yeshurun, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-138630

Published: 2020

Journal Articles

Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial

Odelia Amit, MD, Yael Bar-On, MD, Galit Perets, MD, Lena Atlas, Liat Shargian, MD, Moshe Yeshurun, MD, Bruria Yachini, RN, Chen Karni, RN, Ron Ram, MD

Blood (2019) 134 (Supplement_1): 2018.

https://doi.org/10.1182/blood-2019-126999

Published: 2019

Journal Articles

Is the Achievement of Pre-Autologous Transplant CR Necessary Indeed in Refractory/ Relapsed DLBCL Patients? a Retrospective Multicenter Study

Liat Shargian-Alon, MD, Hanna Bernstine, Galit Perets, MD, Ronit Gurion, Anat Gafter-Gvili, MD, Oren Pasvolsky, MD, Michal Navon Sela, Chava Perry, MD PhD, Irit Avivi, MD, Odelia Amit, MD, Pia Raanani, MD, Ron Ram, MD, Moshe Yeshurun, MD

Blood (2019) 134 (Supplement_1): 5703.

https://doi.org/10.1182/blood-2019-131229

Published: 2019

Journal Articles

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Liat Shargian-Alon, MD, Anat Gafter-Gvili, Ofir Wolach, MD, Moshe Yeshurun, Pia Raanani, Dafna Yahav, MD

Blood (2018) 132 (Supplement 1): 4953.

https://doi.org/10.1182/blood-2018-99-114165

Published: 2018

Journal Articles

Sequential Treatment with FLAG-IDA Salvage Chemotherapy Followed By Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Leukemia

Liat Shargian-Alon, MD, Ofir Wolach, MD, Oren Pasvolsky, Pia Raanani, Moshe Yeshurun

Blood (2018) 132 (Supplement 1): 5788.

https://doi.org/10.1182/blood-2018-99-117301

Published: 2018

Journal Articles

Eltrombopag for Enhancement of Platelet Engraftment in Patients Undergoing Allogeneic Cord Blood Transplantation

Oren Pasvolsky, Liat Shargian, MD, Uri Rozovski, Ron Ram, MD, Michael Y. Shapira, MD, Moshe Israeli, Liat Vidal-Fisher, MD MSc, Ofer Shpilberg, MD MPH, Pia Raanani, Moshe Yeshurun

Blood (2018) 132 (Supplement 1): 2092.

https://doi.org/10.1182/blood-2018-99-116048

Published: 2018

Journal Articles

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, MD, Emmanuelle Polge, Taiga Nishihori, MD, Ali Bazarbachi, MD PhD, Jürgen Finke, MD, Michael Stadler, MD PhD, Gerhard Ehninger, Bruno Lioure, MD, Nicolaas Schaap, Boris V Afanasyev, MD PhD Professor, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, MD PhD, Christoph Schmid, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 273.

https://doi.org/10.1182/blood.V130.Suppl_1.273.273

Published: 2017

Journal Articles

Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis

Moshe Yeshurun, Daniel J. Weisdorf, MD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Mary E. Flowers, MD, Marcos De Lima, MD, Jacob M. Rowe, MD, Brenda M. Sandmaier, MD, Martin S. Tallman, MD, Michael R Verneris, MD, Veronika Bachanova, MD PhD

Blood (2017) 130 (Supplement 1): 518.

https://doi.org/10.1182/blood.V130.Suppl_1.518.518

Published: 2017

NARROW

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Belumosudil Is Efficacious for the Management of Heavily Pretreated and Prolonged Chronic Graft-Versus-Host Disease: A Retrospective Multi-Center Real-World Study By the Israel Association for Bone Marrow Transplantation and Cellular Therapy

Impact of Premedication Prior to Platelet Transfusion on Platelet Increment Among Hemato-Oncological Patients

Utility of Echocardiogram in Neutropenic Patients with Gram Positive Bacteremia: A Retrospective Study

Efficacy of Luspatercept in Low-Risk Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Safety and Efficacy of FLAG-Ida Combined with Venetoclax Treatment for Newly Diagnosed and Relapsed / Refractory AML Patients- a Systematic Review

Sequential Therapy Vs. Salvage Chemotherapy for Patients with AML Refractory to First Induction Regimen- a Bi-Institutional Retrospective Cohort Analysis

Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience

Humoral Serologic Response to the BNT162b2 Vaccine Afterallogeneic Haematopoietic Cell Transplantation

Extracorporeal Photopheresis Induces Netosis in Neutrophils Derived from Patients with Graft-Versus-Host Disease

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission after 5-Azacitidine and Venetoclax: A Multicenter Retrospective Study

A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study

Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation - the Diagnostic Yield of Stool Cultures

Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial

Is the Achievement of Pre-Autologous Transplant CR Necessary Indeed in Refractory/ Relapsed DLBCL Patients? a Retrospective Multicenter Study

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Sequential Treatment with FLAG-IDA Salvage Chemotherapy Followed By Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Leukemia

Eltrombopag for Enhancement of Platelet Engraftment in Patients Undergoing Allogeneic Cord Blood Transplantation

Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only